Analyst Reco. Immix Biopharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
5.560 ^USD	+14.88%		+30.82%	+152.73%

Nov. 12	Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	CI
Nov. 07	Immix Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

HC Wainwright Initiates Immix Biopharma at Buy With $7 Price Target	24-07-01	MT
Roth MKM Initiates Immix Biopharma to Buy Rating With $14 Price Target	23-02-22	MT

No results for this search